Literature DB >> 6150859

Control of transmitter release in guinea-pig vas deferens by prejunctional P1-purinoceptors.

P Sneddon, L A Meldrum, G Burnstock.   

Abstract

The specific P1-purinoceptor agonist 2-chloroadenosine (3 X 10(-7) M to 3 X 10(-6) M) reduced the magnitude of excitatory junction potentials (e.j.p.s) recorded from guinea-pig vas deferens in response to field stimulation of the sympathetic nerves, but did not have any direct effect on the resting membrane potential. Trains of pulses (2-16 Hz) for 20 s produced a biphasic contractile response, both phases of which were reduced by 2-chloroadenosine (10(-7) to 10(-5) M) by up to 45%. In contrast, the same concentrations of 2-chloroadenosine enhanced by about 20% the contractile response of the vas deferens to exogenously applied adenosine 5'-triphosphate (ATP) and noradrenaline (NA). The specific P1-purinoceptor antagonist 8-phenyltheophylline (8-PT) reversed the inhibitory effect of 2-chloroadenosine on e.j.p. magnitude, partially reversed the inhibitory action of 2-chloroadenosine on both phases of the contractile response to nerve stimulation, and partially reversed the enhancing effect of 2-chloroadenosine on responses to exogenous ATP and NA. We propose that release of ATP and NA (as cotransmitters) from sympathetic nerves can be modulated by prejunctional P1-purinoceptors.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6150859     DOI: 10.1016/0014-2999(84)90621-6

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  19 in total

1.  Enhancement of sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens by the novel ecto-ATPase inhibitor ARL 67156.

Authors:  T D Westfall; C Kennedy; P Sneddon
Journal:  Br J Pharmacol       Date:  1996-03       Impact factor: 8.739

2.  Proceedings of the British Pharmacological Society. 6th-8th January, 1988. Abstracts.

Authors: 
Journal:  Br J Pharmacol       Date:  1988-03       Impact factor: 8.739

3.  Junctional transmission in renin-containing and smooth muscle cells of the afferent arteriole.

Authors:  C P Bührle; H Scholz; R Nobiling; R Taugner
Journal:  Pflugers Arch       Date:  1986-06       Impact factor: 3.657

Review 4.  Nervous control of smooth muscle by transmitters, cotransmitters and modulators.

Authors:  G Burnstock
Journal:  Experientia       Date:  1985-07-15

5.  Individual sympathetic varicosities possess different sensitivities to alpha 2 and P2 receptor agonists and antagonists in mouse vas deferens.

Authors:  S C O'Connor; K L Brain; M R Bennett
Journal:  Br J Pharmacol       Date:  1999-12       Impact factor: 8.739

6.  The effect of P2 receptor antagonists and ATPase inhibition on sympathetic purinergic neurotransmission in the guinea-pig isolated vas deferens.

Authors:  P Sneddon; T D Westfall; L D Todorov; S M Todorova; D P Westfall; P Nickel; C Kennedy
Journal:  Br J Pharmacol       Date:  2000-03       Impact factor: 8.739

7.  The fade of the purinergic neurogenic contraction of the guinea-pig vas deferens: analysis of possible mechanisms.

Authors:  B Driessen; I von Kügelgen; R Bültmann; D B Elrick; T C Cunnane; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-11       Impact factor: 3.000

8.  Angiotensin neuromodulation of adrenergic and purinergic co-transmission in the guinea-pig vas deferens.

Authors:  J L Ellis; G Burnstock
Journal:  Br J Pharmacol       Date:  1989-08       Impact factor: 8.739

9.  Comparison between sympathetic adrenergic and purinergic transmission in the dog mesenteric artery.

Authors:  I Muramatsu; T Ohmura; M Oshita
Journal:  J Physiol       Date:  1989-04       Impact factor: 5.182

10.  P1-purinoceptor-mediated modulation of neural noradrenaline and ATP release in guinea-pig vas deferens.

Authors:  B Driessen; I von Kügelgen; K Starke
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1994-07       Impact factor: 3.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.